{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:50:02Z","timestamp":1793724602807,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11239-021-02457-9","type":"journal-article","created":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T17:02:37Z","timestamp":1618678957000},"page":"497-503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7971-6591","authenticated-orcid":false,"given":"A","family":"Marco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3412-7566","authenticated-orcid":false,"given":"P","family":"Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,17]]},"reference":[{"key":"2457_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijid.2020.03.004","volume":"94","author":"D Wu","year":"2020","unstructured":"Wu D, Wu T, Liu Q, Yang Z (2020) The SARS-CoV-2 outbreak: what we know. Int J Infect Dis 94:44\u201348","journal-title":"Int J Infect Dis"},{"key":"2457_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","volume":"18","author":"J Thachil","year":"2020","unstructured":"Thachil J, Tang N, Gando S et al (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 18:1023\u20131026","journal-title":"J Thromb Haemost"},{"key":"2457_CR3","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1111\/jth.14849","volume":"18","author":"JM Connors","year":"2020","unstructured":"Connors JM, Levy JH (2020) Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost 18:1559\u20131561","journal-title":"J Thromb Haemost"},{"key":"2457_CR4","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/jth.14854","volume":"18","author":"M Ranucci","year":"2020","unstructured":"Ranucci M, Ballotta A, Di Dedda U et al (2020) The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost 18:1747\u20131751","journal-title":"J Thromb Haemost"},{"key":"2457_CR5","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18:844\u2013847","journal-title":"J Thromb Haemost"},{"key":"2457_CR6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. Lancet 395:497\u2013506","journal-title":"Lancet"},{"key":"2457_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s11239-020-02182-9","volume":"50","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Cao W, Jiang W et al (2020) Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients. J Thromb Thrombolysis 50:580\u2013586","journal-title":"J Thromb Thrombolysis"},{"key":"2457_CR8","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/jth.14942","volume":"18","author":"TJ Forum","year":"2020","unstructured":"Forum TJ (2020) The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states. J Thromb Haemost 18:1849\u20131852","journal-title":"J Thromb Haemost"},{"key":"2457_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJMc2013656","volume":"383","author":"L Bowles","year":"2020","unstructured":"Bowles L, Platton S, Yartey N et al (2020) Lupus anticoagulant and abnormal coagulation tests in patients with COVID-19. N Engl J Med 383:288\u2013290","journal-title":"N Engl J Med"},{"key":"2457_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","volume":"506","author":"G Lippi","year":"2020","unstructured":"Lippi G, Plebani M, Henry BM (2020) Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 506:145\u2013148","journal-title":"Clin Chim Acta"},{"key":"2457_CR11","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/jth.14850","volume":"18","author":"M Panigada","year":"2020","unstructured":"Panigada M, Bottino N, Tagliabue P et al (2020) Hypercoagulability of COVID-19 patients in the intensive care unit: a report of the thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 18:1738\u20131742","journal-title":"J Thromb Haemost"},{"key":"2457_CR12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1715841","author":"UK Katneni","year":"2020","unstructured":"Katneni UK, Alexaki A, Hunt RC et al (2020) Coagulopathy and thrombosis as a result of severe COVID-19 infection: a microvascular focus. Thromb Haemost. https:\/\/doi.org\/10.1055\/s-0040-1715841","journal-title":"Thromb Haemost"},{"key":"2457_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11239-020-02130-7","volume":"50","author":"V Pavoni","year":"2020","unstructured":"Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri FC (2020) Evaluation of coagulation function by rotation thrombelastometry in critically ill patients with severe COVID19 pneumonia. J Thromb Thrombolysis 50:281\u2013286","journal-title":"J Thromb Thrombolysis"},{"key":"2457_CR14","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1111\/jth.15043","volume":"18","author":"A Blasi","year":"2020","unstructured":"Blasi A, Von Meijenfeldt FA, Adelmeijer J et al (2020) In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis on COVID-19 patients on anticoagulation. J Thromb Haemost 18:2646\u20132653","journal-title":"J Thromb Haemost"},{"key":"2457_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/IJLH.13329","author":"D White","year":"2020","unstructured":"White D, MacDonald S, Edwards T et al (2020) Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays. Int J Lab Hematol. https:\/\/doi.org\/10.1111\/IJLH.13329","journal-title":"Int J Lab Hematol"},{"key":"2457_CR16","doi-asserted-by":"publisher","first-page":"5620314","DOI":"10.1155\/2017\/5620314","volume":"2017","author":"F Gragnano","year":"2017","unstructured":"Gragnano F, Sperlongano S, Golia E et al (2017) The role of von Willebrand factor in vascular inflammation: from pathogenesis to targeted therapy. Mediators Inflamm 2017:5620314","journal-title":"Mediators Inflamm"},{"key":"2457_CR17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11739-020-02394-0","volume":"15","author":"M Bazzan","year":"2020","unstructured":"Bazzan M, Montaruli B, Sciascia S, Cosseddu D, Norbiato C, Roccatello D (2020) Low ADAMTS13 plasma levels are predictors of mortality in COVID-19 patients. Intern Emerg Med 15:861\u2013863","journal-title":"Intern Emerg Med"},{"key":"2457_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/ijlh.13244","volume":"42","author":"A Huisman","year":"2020","unstructured":"Huisman A, Beun R, Sikma M, Westerink J, Kusadasi N (2020) Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2. Int J Lab Hematol 42:211\u2013212","journal-title":"Int J Lab Hematol"},{"key":"2457_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.thromres.2020.06.026","volume":"194","author":"EH Adam","year":"2020","unstructured":"Adam EH, Zacharowski K, Miesbach W (2020) A comprehensive assessment of the coagulation profile in critically ill COVID-19 patients. Thromb Res 194:42\u201344","journal-title":"Thromb Res"},{"key":"2457_CR20","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/jth.14929","volume":"18","author":"AC Spyropoulos","year":"2020","unstructured":"Spyropoulos AC, Levy JH, Ageno W et al (2020) Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost 18:1859\u20131865","journal-title":"J Thromb Haemost"},{"key":"2457_CR21","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.chest.2020.05.559","volume":"158","author":"LK Moores","year":"2020","unstructured":"Moores LK, Tritschler T, Brosnahan S et al (2020) Prevention, diagnosis, and treatment of venous thromboembolism in patients with COVID-19: CHEST guideline and expert panel report. Chest 158:1143\u20131163","journal-title":"Chest"},{"key":"2457_CR22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/jth.12155","volume":"11","author":"H Wada","year":"2013","unstructured":"Wada H, Thachil J, Di Nisio M et al (2013) Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost 11:761\u2013767","journal-title":"J Thromb Haemost"},{"key":"2457_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26232","author":"B Hu","year":"2020","unstructured":"Hu B, Huang S, Yin L (2020) The cytokine storm and COVID-19. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.26232","journal-title":"J Med Virol"},{"key":"2457_CR24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang B, Mao J (2020) The pathogenesis and treatment of the cytokine storm in COVID19. J Infectol 80:607\u2013613","journal-title":"J Infectol"},{"key":"2457_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/JTH.15191","author":"I Mancini","year":"2020","unstructured":"Mancini I, Baronciani L, Artoni A et al (2020) The ADAMTS13-von Willebrand factor axis in COVID-19 patients. J Thromb Haemost. https:\/\/doi.org\/10.1111\/JTH.15191","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02457-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-021-02457-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02457-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T05:11:13Z","timestamp":1635225073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-021-02457-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,17]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2457"],"URL":"https:\/\/doi.org\/10.1007\/s11239-021-02457-9","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,17]]},"assertion":[{"value":"13 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}